These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 15680459)

  • 41. Treatment guidelines for hepatic encephalopathy.
    Thompson JR
    Pharmacotherapy; 2010 May; 30(5 Pt 2):4S-9S. PubMed ID: 20412034
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Predictors of the recurrence of hepatic encephalopathy in lactulose-treated patients.
    Bajaj JS; Sanyal AJ; Bell D; Gilles H; Heuman DM
    Aliment Pharmacol Ther; 2010 May; 31(9):1012-7. PubMed ID: 20136802
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pathophysiology, diagnosis, and management of hepatic encephalopathy.
    Sheasgreen C; Lu L; Patel A
    Inflammopharmacology; 2014 Dec; 22(6):319-26. PubMed ID: 25300964
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatic Encephalopathy: Pharmacological Therapies Targeting Ammonia.
    Rahimi RS; Rockey DC
    Semin Liver Dis; 2016 Feb; 36(1):48-55. PubMed ID: 26870932
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical efficacy and safety of lactulose for minimal hepatic encephalopathy: a meta-analysis.
    Luo M; Li L; Lu CZ; Cao WK
    Eur J Gastroenterol Hepatol; 2011 Nov; 23(12):1250-7. PubMed ID: 21971378
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Hepatic encephalopathy. Early therapy is most important!].
    MMW Fortschr Med; 2014 Nov; 156(19):28. PubMed ID: 25510011
    [No Abstract]   [Full Text] [Related]  

  • 47. [Treatment of cirrhotic encephalopathy].
    Thaler H
    Med Chir Dig; 1976; 5(3):149-51. PubMed ID: 1004044
    [No Abstract]   [Full Text] [Related]  

  • 48. The treatment of chronic hepatic encephalopathy.
    Morgan MY
    Hepatogastroenterology; 1991 Oct; 38(5):377-87. PubMed ID: 1662661
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Low-protein diets for hepatic encephalopathy debunked: let them eat steak.
    Cabral CM; Burns DL
    Nutr Clin Pract; 2011 Apr; 26(2):155-9. PubMed ID: 21447768
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Role of Sarcopenia and Frailty in Hepatic Encephalopathy Management.
    Lucero C; Verna EC
    Clin Liver Dis; 2015 Aug; 19(3):507-28. PubMed ID: 26195205
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Confusion and abnormal liver enzyme levels: problems with diagnosing hepatic encephalopathy].
    Hendriks ME; van Westerloo DJ; Portegies P
    Ned Tijdschr Geneeskd; 2007 Dec; 151(49):2701-6. PubMed ID: 18225787
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Hepatic encephalopathies].
    Gerok W
    Infusionsther Klin Ernahr; 1987 Oct; 14 Suppl 5():43-9. PubMed ID: 2893770
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis.
    Liu Q; Duan ZP; Ha DK; Bengmark S; Kurtovic J; Riordan SM
    Hepatology; 2004 May; 39(5):1441-9. PubMed ID: 15122774
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Beyond Lactulose: Treatment Options for Hepatic Encephalopathy.
    Said VJ; Garcia-Trujillo E
    Gastroenterol Nurs; 2019; 42(3):277-285. PubMed ID: 31145253
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical management of hepatic encephalopathy.
    Schiano TD
    Pharmacotherapy; 2010 May; 30(5 Pt 2):10S-5S. PubMed ID: 20412035
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bifidobacterium combined with fructo-oligosaccharide versus lactulose in the treatment of patients with hepatic encephalopathy.
    Malaguarnera M; Gargante MP; Malaguarnera G; Salmeri M; Mastrojeni S; Rampello L; Pennisi G; Li Volti G; Galvano F
    Eur J Gastroenterol Hepatol; 2010 Feb; 22(2):199-206. PubMed ID: 19730107
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Secondary prophylaxis of hepatic encephalopathy in cirrhosis: an open-label, randomized controlled trial of lactulose, probiotics, and no therapy.
    Agrawal A; Sharma BC; Sharma P; Sarin SK
    Am J Gastroenterol; 2012 Jul; 107(7):1043-50. PubMed ID: 22710579
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Therapy of portosystemic encephalopathy].
    Ventrella F; Tardi S; Palmieri V
    Clin Ter; 1986 May; 117(4):317-28. PubMed ID: 3731738
    [No Abstract]   [Full Text] [Related]  

  • 59. Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.
    Kircheis G; Nilius R; Held C; Berndt H; Buchner M; Görtelmeyer R; Hendricks R; Krüger B; Kuklinski B; Meister H; Otto HJ; Rink C; Rösch W; Stauch S
    Hepatology; 1997 Jun; 25(6):1351-60. PubMed ID: 9185752
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dietary and nutritional indications in hepatic encephalopathy.
    Merli M; Riggio O
    Metab Brain Dis; 2009 Mar; 24(1):211-21. PubMed ID: 19052853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.